New Delhi, Nov. 24 -- Global brokerage firm UBS, in its latest note, initiated coverage on Shaily Engineering Plastics, the country's leading exporter of high-precision engineered plastic products and components, with a 'Buy' rating and a record target price of Rs.4,000. This implies an upside potential of 60% from the stock's latest closing price.

According to UBS, Shaily is one of the few global companies with patented technology for fixed-dose and auto-injector pens, positioning it strongly for the launch of generic GLP-1 therapies. The brokerage believes the market is significantly underestimating both the scale of this opportunity and Shaily's capability to capitalise on it.

UBS said that the GLP-1 (semaglutide) patent is set to ex...